Evidence-based pharmacy evaluation of Ruyi Jinhuang Powder for treating phlebitis / 中国药学杂志
Chinese Pharmaceutical Journal
;
(24): 1860-1864, 2012.
Article
in Chinese
| WPRIM
| ID: wpr-860570
ABSTRACT
OBJECTIVE:
To evaluate the therapeutic effect and safety of Ruyi Jinhuang Powder for phlebitis.METHODS:
The Cochrane Library, PubMed database, Embase database, ISI database, CBM database, CNKI database, VIP Database, and Wanfang database were searched. Randomized controlled trials (RCT), systematic reviews (SR)and meta-analysis of treating phlebitis by Ruyi Jinhuang Powder and 50% magnesium sulfate were included. Methodological quality assessment and meta-analysis of randomized controlled trials were carried out, and the conclusions of the included systematic reviews and meta-analyses were referred to.RESULTS:
Ten RCTs comparing Ruyi Jinhuang Powder and 50% magnesium sulfate for treatment of phlebitis were included into the analysis. The total efficiencies of the two drugs had statistical significance [RR 12.96, 95% CI (5.81, 28.89), P 0.05].CONCLUSION:
Ruyi Jinhuang Powder is effective for treating phlebitis, the therapeutic effect is better than 50% magnesium sulfate, and no adverse drug reaction has been reported.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Chinese Pharmaceutical Journal
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS